Showing results (21-30 of 64) with videos related to

Sort By:
Pageof 7
Journal of the National Cancer Institute|July 9, 2004
Cellular effects and antitumor activity of RET inhibitor RPI-1 on MEN2A-associated medullary thyroid carcinomaGiuditta Cuccuru, Cinzia Lanzi, Giuliana Cassinelli, et al.
Cancers|July 25, 2019
Could Circulating Tumor Cells and ARV7 Detection Improve Clinical Decisions in Metastatic Castration-Resistant Prostate Cancer? The Istituto Nazionale dei Tumori (INT) ExperiencePierangela Sepe, Elena Verzoni, Patrizia Miodini, et al.
Cancer Chemotherapy and Pharmacology|August 29, 2006
Are capecitabine and oxaliplatin (XELOX) suitable treatments for progressing low-grade and high-grade neuroendocrine tumours?Emilio Bajetta, Laura Catena, Giuseppe Procopio, et al.
Tumori|March 15, 2005
Treatment options in hormone-refractory metastatic prostate carcinomaAlberto Fusi, Giuseppe Procopio, Silvia Della Torre, et al.
Tumori|May 14, 2016
Body mass index and clinical benefit of fulvestrant in postmenopausal women with advanced breast cancerArpine Gevorgyan, Giacomo Bregni, Giulia Galli, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|April 12, 2015
Osteopontin, E-cadherin, and β-catenin expression as prognostic biomarkers in patients with radically resected gastric cancerMaria Di Bartolomeo, Filippo Pietrantonio, Alessandro Pellegrinelli, et al.
World Journal of Clinical Cases|December 18, 2014
Role of MGMT as biomarker in colorectal cancerAlessandro Inno, Giuseppe Fanetti, Maria Di Bartolomeo, et al.
Cancers|September 27, 2014
Circulating biomarkers in advanced colorectal cancer patients randomly assigned to three bevacizumab-based regimensAntonia Martinetti, Rosalba Miceli, Elisa Sottotetti, et al.
American Journal of Clinical Oncology|September 5, 2020
Prospective Translational Study Investigating Molecular PrEdictors of Resistance to First-Line PazopanIb in Metastatic reNal CEll Carcinoma (PIPELINE Study)Pierangela Sepe, Antonia Martinetti, Alessia Mennitto, et al.
International Journal of Cancer|February 24, 2015
Circulating tumor cells as a longitudinal biomarker in patients with advanced chemorefractory, RAS-BRAF wild-type colorectal cancer receiving cetuximab or panitumumabValeria Musella, Filippo Pietrantonio, Eleonora Di Buduo, et al.
Pageof 7